Wuhan Hamilton Bio-technology Co., Ltd Report issue

For profit
Founded: Wuhan China (2013)
Status: Defunct (2020)

Organization Overview

First Clinical Trial
2020
NCT04273646
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Wuhan Hamilton Bio-technology Co., Ltd | Wuhan Hamilton Biotechnology Co., Ltd | Wuhan Hamilton Bio-technology Co., Ltd, China.

Active Ingredients

Drugs in Other Trials (1)

umbilical cord mesenchymal stem cells (3 trials)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 3
  • # of Trial APIs: 1